The Swiss Multiple Sclerosis (MS) Society described at the European Health Forum Gastein pioneering methods for employers to retain workers with MS, an illness that affects 500,000 people across Europe and costs €15bn annually in direct and indirect costs. Tailor-made case management had been a signal success in a pilot project at Ford-Werke Deutschland, where 500 workers with chronic disability have been reintegrated in the workforce. A pilot project for associates with MS at Novartis AG, Switzerland, is ongoing.